Singapore markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
57.14-0.33 (-0.57%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6677
Avg. Estimate2.443.617.865.11
Low estimate2.152.827.023.42
High estimate2.735.469.766.97
Year ago EPS2.193.677.887.86
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7777
Avg. Estimate486.84M575.39M1.8B1.49B
Low estimate454M535.4M1.73B1.37B
High estimate517.6M601.9M1.84B1.65B
Year ago sales385.2M583M1.56B1.8B
Sales growth (year/est)26.40%-1.30%15.90%-17.30%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS2.123.191.121.54
Actual EPS2.193.671.530.33
Difference0.070.480.41-1.21
Surprise %3.30%15.00%36.60%-78.60%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate2.443.617.865.11
7 days ago2.443.617.925.13
30 days ago2.443.617.925.13
60 days ago2.22.828.085.05
90 days ago2.242.848.155.11
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimatesEBSIndustrySector(s)S&P 500
Current qtr.11.40%N/AN/AN/A
Next qtr.-1.60%N/AN/AN/A
Current year-0.30%N/AN/AN/A
Next year-35.00%N/AN/AN/A
Next 5 years (per annum)9.20%N/AN/AN/A
Past 5 years (per annum)0.19%N/AN/AN/A